Age-standardized mortality-to-incidence ratio for lung cancer in the world.

Jpn J Clin Oncol

Division of International Health Policy Research, Institute for Cancer Control, National Cancer Center, Chuo-ku, Tokyo, Japan.

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyaf006DOI Listing

Publication Analysis

Top Keywords

age-standardized mortality-to-incidence
4
mortality-to-incidence ratio
4
ratio lung
4
lung cancer
4
age-standardized
1
ratio
1
lung
1
cancer
1

Similar Publications

Age-standardized mortality-to-incidence ratio for lung cancer in the world.

Jpn J Clin Oncol

January 2025

Division of International Health Policy Research, Institute for Cancer Control, National Cancer Center, Chuo-ku, Tokyo, Japan.

View Article and Find Full Text PDF

Background: Cutaneous melanoma (CM) is the leading cause of skin cancer mortality with associated high healthcare costs. Up-to-date reporting of epidemiological trends for CM is required to project future trends, assess the burden of disease and aid evaluation of new diagnostic, therapeutic and preventative strategies.

Objectives: To describe the trends in CM mortality, incidence, mortality-to-incidence indices (MIIs) and disability-adjusted life years (DALYs) over the last three decades.

View Article and Find Full Text PDF

Background & objectives Cancer is one of the leading causes of death among older adults worldwide. The global burden of cancer among older individuals is increasing due to the ageing population. The increasing burden of cancer among older adults will pose significant social and economic challenges for the delivery of healthcare services.

View Article and Find Full Text PDF

Background: Tracheal Bronchus and Lung cancers (TBL) represent one of the leading causes of cancer deaths worldwide. This study aimed to examine the disease and economic burden of TBL cancers in 185 countries worldwide in 2022.

Methods: The estimates of TBL cancer incidence and mortality (counts and age-standardized rates) were obtained from the GLOBOCAN 2022 data produced by the International Agency for Research on Cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!